Výsledky vyhledávání

Low-molecular-weight heparin as prophylaxis against thromboembolism after total hip replacement--The never-ending story?

Autor: O E Dahl, D Bergqvist, A T Cohen, S P Frostick, R D Hull, B M Persson

Publikováno v: Acta Orthopaedica Scandinavica. 72:199-204

Low-molecular-weight heparin prophylaxis against thromboembolism aftertotal hip replacement--the never-ending story?

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b54f657fa08f00636a4481ed14520d0
https://doi.org/10.1080/000164701317323507

Zobrazit plný text záznamu

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial

Autor: B. I . ERIKSSON, O. E. DAHL, N. ROSENCHER, A. A. KURTH, C. N. VAN DIJ K, S . P. FROSTICK, P. KALEBO, A. V. CHRISTIANSEN, S . HANTEL, R. HETTIARACHCHI, J . SCHNEE, H. R. BULLER, FOR THE RE-MODEL STUDY GROUP, BATTISTA BORGHI

Publikováno v: Journal of thrombosis and haemostasis, 5(11), 2178-2185. Wiley-Blackwell

Summary. Background: Oral anticoagulants, such as dabigatran etexilate, an oral, direct thrombin inhibitor, that do not require monitoring or dose adjustment offer potential for prophylaxis against venous thromboembolism (VTE) after total knee replac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecff8aab35b764ee6cc072ef8dbee5b3
http://hdl.handle.net/11585/56816

Zobrazit plný text záznamu

Orthopaedic thromboprophylaxis: limitations of current guidelines

Autor: D, Warwick, O E, Dahl, W D, Fisher, B, Jacobsen

Publikováno v: The Journal of bone and joint surgery. British volume. 90(2)

Thromboprophylaxis remains a controversial subject. A vast amount of epidemiological and trial data about venous thromboembolism has been published over the past 40 years. These data have been distilled and synthesised into guidelines designed to hel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e338f117abe45d53506b50f5517ccd6c
https://pubmed.ncbi.nlm.nih.gov/18256075

Zobrazit plný text záznamu

Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran

Autor: G, Agnelli, B I, Eriksson, A T, Cohen, D, Bergqvist, O E, Dahl, M R, Lassen, P, Mouret, N, Rosencher, M, Andersson, A, Bylock, E, Jensen, B, Boberg

Publikováno v: Thrombosis research, 123(3), 488-497. Elsevier Limited

Background Ximelagatran, the first oral direct thrombin inhibitor, was shown to be an effective antithrombotic agent but was associated with potential liver toxicity after prolonged administration. Objectives and Methods The aim of the EXTEND study w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1019fa706ec92e102dfee7db5e2b5b73
https://pubmed.ncbi.nlm.nih.gov/18485453

Zobrazit plný text záznamu

Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement

Autor: O. E. Dahl, A. M. Pleil

Publikováno v: Journal of thrombosis and haemostasis : JTH. 1(5)

Summary. Clinical guidelines recommend the use of extended out-of-hospital thromboprophylaxis in patients who have had major arthroplasty. However, the cost-effectiveness of prolonging pharmacological thromboprophylaxis into the out-of-hospital phase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e65c0609770c0288e5503f4ec818a967
https://pubmed.ncbi.nlm.nih.gov/12871354

Zobrazit plný text záznamu

Mechanisms of hypercoagulability

Autor: O E, Dahl

Publikováno v: Thrombosis and haemostasis. 82(2)

Following certain major operative procedures, large amounts of tissue factor may be released from damaged tissues to venous blood. Mechanical and chemical injury to the collecting veins exposes subendothelial procoagulant proteins. This initiates a m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4263d26528336155071231d722fae4bd
https://pubmed.ncbi.nlm.nih.gov/10605801

Zobrazit plný text záznamu

Effects of hip replacement surgery on the haemostatic system

Autor: O. E. Dahl

Publikováno v: UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36a19dc85869694651a3e1576364c26e
https://doi.org/10.5821/sibb.v7i1.1635

Zobrazit plný text záznamu

[Clinical diagnosis of deep venous thrombosis after hip replacement surgery]

Autor: G, Andreassen, O E, Dahl

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 117(14)

Hip replacement surgery is associated with a high frequency of postoperative deep vein thrombosis. This prospective study was performed in order to investigate if routine bedside questioning and examination by the visiting doctor could reveal deep ve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c9e91b2c2afe8c9e465656a6c4c9998f
https://pubmed.ncbi.nlm.nih.gov/9441453

Zobrazit plný text záznamu

Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin)

Autor: O E, Dahl, G, Andreassen, T, Aspelin, C, Müller, P, Mathiesen, S, Nyhus, M, Abdelnoor, J H, Solhaug, H, Arnesen

Publikováno v: Thrombosis and haemostasis. 77(1)

Discontinuation of thromboprophylaxis a few days after surgery may unmask delayed hypercoagulability and contribute to late formation of deep venous thrombosis (DVT). To investigate whether thromboprophylaxis should be prolonged beyond the hospital s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cba47f9ba06e2e4797100c95cb89b3e7
https://pubmed.ncbi.nlm.nih.gov/9459353

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání